Latest
23
Apr
Fund of the week: OMERS Life Sciences
Fund Snapshot
Firm
OMERS Life Sciences (division of OMERS Capital Markets)
Parent
Ontario Municipal Employees Retirement System (OMERS)
Established
2016
23 min read
22
Apr
The Co-Funding Royalty: Phase III Co-Investment, Synthetic Revenue Interests, and How BD Teams Position the Hybrid Proposal
Somewhere between a licence, a loan, and an equity investment — but structurally none of these — sits a transaction type that
15 min read
21
Apr
Medical Device Royalty Financing: Deal Mechanics, Structural Precedent, and Royalty-Readiness Thresholds
Pure medical device royalty monetization remains a small segment of the life sciences non-dilutive capital market. Of Gibson Dunn'
15 min read
20
Apr
Why Norway Does Not Have a Pharmaceutical Royalty Fund Yet
Notes from the 7th Norwegian Life Science Investor Partnering Day on what Norway has, what is missing, and how a Norwegian pharmaceutical royalty fund could actually be put together.
13 min read
19
Apr
The Weekly Term Sheet (2026-W16)
W16 opened with Friday holdovers and closed with a Friday evening headlined by UCB's up to $1.15
102 min read
18
Apr
The Tax Architecture of Royalty Funds: How Jurisdiction Shopping Shapes Pharmaceutical Finance
When Royalty Pharma filed its S-1 prospectus ahead of its 2020 IPO, the organizational chart told a story that no
21 min read
17
Apr
Company of the week: Opus Genetics
Opus Genetics is a Research Triangle Park, North Carolina-based clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases (IRDs)
22 min read
16
Apr
Fund of the week: Jeito Capital
Fund Snapshot
Firm
Jeito Capital
Fund I
Jeito I, €534M ($630M), final close September 2021
Fund II
Jeito II, >
19 min read
15
Apr
Revolving Credit Facilities in Pharmaceutical Financing
Understanding the instrument that sits behind every major royalty fund's capital structure and every commercial-stage biotech's liquidity toolkit — how revolvers work, why they matter, and how they interact with royalty financing transactions.
17 min read
14
Apr
Royalty on Net Sales vs. Net Profits: Why the Definition of the Base Matters More Than the Rate
When two pharmaceutical companies or a biotech and a royalty fund negotiate a royalty agreement, the headline debate is almost
16 min read